Pleased to share new work from us showing effects of elexacaftor/tezacaftor/ivacaftor (ETI) therapy on the function and quality of the T cell compartment in people with cystic fibrosis, both in the airways and systemically.
@ki.se #cysticfibrosis #Tcells #MAIT
rdcu.be/e06Rw